Cochlear Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 2.15 per share for the six months ending December 2025, payable in April 2026 across multiple currencies.
- Ordinary dividend of AUD 2.15 per share for H2 2025
- Dividend 85% franked with 30% corporate tax rate
- Payment date set for 13 April 2026
- Dividends payable in AUD, GBP, NZD, and USD based on shareholder location
- Exchange rates fixed as of 20 March 2026
Dividend Update and Payment Details
Cochlear Limited has provided an update to its previously announced dividend distribution, confirming an ordinary dividend of AUD 2.15 per fully paid ordinary share for the six months ending 31 December 2025. This dividend is scheduled for payment on 13 April 2026, with the record date set at 20 March 2026 and an ex-dividend date of 19 March 2026.
The dividend is 85% franked, reflecting the company’s ability to pass on franking credits to shareholders at the prevailing corporate tax rate of 30%. This means investors will receive a substantial tax credit alongside their dividend payments, a feature that often appeals to Australian shareholders seeking tax-efficient income streams.
Multi-Currency Payment Arrangements
In a notable update, Cochlear has clarified its currency payment arrangements. Dividends will be paid in four currencies: Australian dollars (AUD), British pounds (GBP), New Zealand dollars (NZD), and US dollars (USD). The currency paid depends on the shareholder’s registered address, with payments defaulting to AUD for shareholders outside the UK, New Zealand, and the US.
The exchange rates used for converting the dividend from AUD to the other currencies were fixed as of 20 March 2026, with the corresponding payments released to the ASX on 23 March 2026. For example, the NZD equivalent dividend per share is approximately NZD 2.59, reflecting an exchange rate of 1.2067 NZD per AUD.
Implications for Investors
This update provides clarity for investors on the timing and currency of dividend payments, which is particularly important for international shareholders managing currency risk. The absence of any required approvals before the payment date suggests a smooth distribution process ahead.
Notably, Cochlear does not operate a securities plan for dividends, indicating that all payments will be made in cash rather than reinvested shares. This straightforward approach aligns with the company’s consistent dividend policy and supports income-focused investors.
Overall, the update reinforces Cochlear’s commitment to delivering shareholder returns while accommodating the diverse geographic footprint of its investor base.
Bottom Line?
As Cochlear prepares to pay its fully franked dividend in multiple currencies, investors will be watching exchange rates closely ahead of April’s payment date.
Questions in the middle?
- Will Cochlear maintain or increase its dividend in future periods amid global economic uncertainties?
- How might currency fluctuations between announcement and payment dates affect foreign shareholders’ returns?
- Could Cochlear consider introducing a dividend reinvestment plan to offer more flexibility to investors?